Free oxygen radicals and intracellular calcium homeostasis play important roles in the development of myocardial reperfusion injury. Propofol is a radical scavenger with calcium channel blocking properties. We have investigated the effects of propofol on myocardial reperfusion injury. We used an isolated rat heart model where heart rate, ventricular volume and perfusion pressure were constant. The left anterior descending coronary artery (LAD) was occluded for 30 min and reperfused for 2 h. We studied an untreated control group, an Intralipid group (I JLXI ml" 1 ) and a propofol group (Intralipid I fil ml" 1 and propofol I jig ml" 1 ) (n= 12 each). Drugs were infused for 20 min starting 5 min before reperfusion. We measured left ventricular developed pressure (LVDP), coronary flow and infarct size. LAD occlusion reduced mean LVDP from 129 (SEM 4) to 36 (3) mm Hg and mean coronary flow from 12.2 (0.3) to 5.2 (0.2) ml min"" 1 . During reperfusion, LVDP recovered to 98 (4) mm Hg and coronary flow to I 1.9 (0.4) ml min" 1 . Haemodynamic variables were similar in all groups. Propofol had no effect on infarct size compared with the Intralipid group (25.0 (3.7) vs 26.9 (3.3)% of the area at risk; P=0.89). Infarct size in the Intralipid group tended to be smaller compared with the control group (34.8 (3.2)%; P=0.19). We conclude that propofol, at a clinically relevant concentration, provided no protective effect against myocardial reperfusion injury in the rat heart in vitro. BrJAnaesth 1999; 83: 903-8 
" 11 and it has been suggested that it acts ischaemic area.
1 However, reperfusion can initiate additional as a calcium channel blocker.
12 " 14 The beneficial effects of cell damage which limits the amount of potentially salvage-calcium channel blockers on myocardial reperfusion injury able myocardium. This phenomenon is known as 'lethal are well established. 15 16 reperfusion injury' and can be reduced by modification Propofol is being used increasingly in cardiac anaestheof the conditions of reperfusion.
2 Free oxygen radicals, sia 17 in which the heart is subjected to periods of ischaemia generated particularly in the first few minutes of reperfusion, and reperfusion. Under these conditions, a cardioprotective play an important role in the development of reperfusion effect of the anaesthetic may have some clinical relevance. injury. 1 3 Free oxygen radical scavenging drugs such as Therefore, we have investigated if propofol, at clinically superoxide dismutase, given at the onset of reperfusion, relevant concentrations, provides specific protection against can reduce myocardial infarct size. 4 
"
6 Another important lethal reperfusion injury. We used an isolated rat heart factor involved in the development of myocardial reperfu-model so that extrinsic humoral and autonomic nervous sion injury is cellular calcium overload. With the re-supply system influences in addition to the effect of propofol of oxygen, disturbance in cytoplasmic calcium homeostasis on peripheral vascular tone could be excluded. Regional contributes to the development of hypercontracture leading ischaemia was achieved by occlusion of the left anterior to disruption of the cytoskeleton and finally to cell death. the initial reperfusion period so that it was possible to investigate only the effects on reperfusion injury and not on ischaemic injury. Cellular lethal damage was assessed by measuring infarct size.
Material and methods
The study was performed in accordance with the regulations of the German Animal Protection Law and local institutional regulations.
Experimental preparation
We excised hearts from male Wistar rats, weighing 300-350 g, anaesthetized with enflurane, and mounted on a Langendorff perfusion system. Retrograde perfusion was initiated with an oxygenated modified Krebs-Henseleit buffer containing (mmol litre' 1 ): NaCl 116, KC14.7, MgSO 4 1.1, KH 2 PO 4 1.17, NaHCO 3 24.9, CaCl 2 2.52, glucose 8.3 and pyruvate 2.0, and was gassed with 95% oxygen -5% carbon dioxide, which produced a P o . °f 80-100 kPa and a pH of 7.38-7.44. Perfusion pressure was maintained constant at 100 cm H 2 O. The right ventricle was vented via the pulmonary artery with a Teflon catheter (1.2 mm od). In hearts used for the ischaemia-reperfusion experiments, the left anterior descending coronary artery (LAD) was encircled with a suture (6-0 Prolene, Ethicon, Norderstedt, Germany) for later occlusion. Heart rate was maintained at 370 beat min" 1 by left ventricular pacing (2-6 V, 1 ms). Myocardial temperature was measured (GTH 1160, Geisinger-Elektronik, Germany) and kept constant at 38°C. For measurements of left ventricular pressure (LVP), a Latex balloon (size No. 5, Hugo Sachs Elektronik, March, Germany) was introduced into the left ventricle via the cut mitral valve. The balloon was fixed at the tip of a stainless steel cannula (length 5.9 cm) which was connected directly to a pressure transducer (Gould P23, Cleveland, OH, USA). At the beginning of each experiment, the Latex balloon was filled, air-bubble free, with Krebs-Henseleit buffer to achieve an end-diastolic left ventricular pressure of 8 mm Hg. Coronary flow was measured using an ultrasonic flow probe (In-Line-Flowprobe 2N, Transonic Systems Inc., Ithaca, NY, USA) placed in the perfusion system near the aortic cannula. The perfusing system consisted of glass, metal and Teflon only and therefore loss of infused substances in the system could be excluded.
Dose-effect experiments
Six hearts received different concentrations of propofol by infusing an emulsion of a commercial propofol preparation in an Intralipid-Krebs-Henseleit mixture using a perfusion pump (Model 5003, Precidior Infors, Basel, Switzerland). The infusion rate was set to one-hundredth of coronary flow to achieve propofol concentrations of 0.1, 0.5, 1, 2, 4, 6, 8 and 10 \ig ml" 1 together with 10% Intralipid 1 jLtl ml" 1 . Immediately before starting each infusion, baseline measurements of haemodynamic variables (LVP, coronary flow) were performed. Five minutes after starting the infusion, measurements were repeated. Fifteen minutes was allowed between administration of each concentration to allow haemodynamic variables to recover to baseline.
In five additional hearts, different doses of Intralipid were infused in the same manner to achieve concentrations of 0.1, 1, 5 and 10 \i\ ml" 1 .
Ischaemia-reperfusion experiments
Three groups (n-12 each) were studied: propofol, Intralipid and control groups. After preparation, a stabilization period of 20 min was allowed. Baseline measurements were then performed. To initiate regional ischaemia, the LAD was occluded by tightening the Prolene suture over 5 mm of vinyl tubing (1 mm od). After 30 min of regional ischaemia, LAD occlusion was released, followed by 2 h of reperfusion. In the propofol group, a mixture containing propofol 0.1 mg and Intralipid 0.1 ml per millilitre of Krebs-Henseleit buffer was infused during the last 5 min of regional ischaemia and the first 15 min of reperfusion. The infusion rate was one-hundredth of coronary flow to achieve a final perfusate concentration of propofol 1 |ig ml" 1 and Intralipid 1 [i\ ml"
1 . In the Intralipid group, only Intralipid 0.1 ml per millilitre of Krebs-Henseleit was given with the same infusion rate. The control group was untreated.
Myocardial oxygen consumption
Aliquots from the perfusion medium and the coronary venous effluent perfusate were sampled anaerobically. Samples were processed immediately for P o , measurements (ABL 30, Radiometer, Copenhagen, Denmark). Oxygen consumption (VQ 2 ) was calculated according to Fick's principle with the use of Bunsen's absorption coefficient (a' = 0.036 filXmm Hg"
1 Xml" 1 ) at 37°C as follows:
where PSL OI = arterial P o , (kPa), Pv O2 =venous P o , (kPa) and CF=coronary flow (ml min" 1 ).
Measurement of infarct size
After 2 h of reperfusion, the hearts were arrested in diastoleby perfusion with a cardioplegic solution. The LAD was then re-occluded and the hearts perfused with 0.2% Evans blue and 1% dextran in normal saline. This treatment identifies the area at risk as unstained. The hearts were then frozen and cut into transverse slices of 1 mm thickness. The slides were stained in buffered 0.75% triphenyltetrazolium chloride solution (TTC) and incubated in 10% formalin to identify viable and necrotic tissue within the area at risk. The basal side of each slice was scanned (StudioScan Ilsi, AGFA, Leverkusen, Germany) and the area at risk in addition to the infarcted area were determined by planimetry on a personal computer.
Data analysis and statistics
LVP, its first derivative dP/dt and coronary flow were recorded continuously on an ink recorder (Mark 260, Gould, Cleveland, OH, USA). The data were digitized using an analogue-to-digital converter (Data Translation, Marlboro, MA, USA) at a sampling rate of 500 Hz and processed on a personal computer. Twenty sequential cardiac cycles were averaged to compensate for variations. Left ventricular developed pressure (LVDP) as a variable of myocardial contractility was calculated by subtracting left ventricular (LV) end-diastolic pressure from LV systolic pressure. All data are expressed as mean (SEM) and 95% confidence intervals (CI) if indicated. In the ischaemia-reperfusion experiments, statistical analysis was performed using ANOVA with Dunnett's post hoc test comparing the control and propofol groups with the Intralipid group. If ANOVA showed a time effect within a group, Dunnett's test was used as a post hoc test to compare each recorded value of the variable with its baseline value. In the dose-effect experiments, each control was compared with the respective intervention (drug administration) using the Student's t test for paired observations. Differences with P<0.05 were regarded as significant. Figure 1 shows the effect of propofol and Intralipid on haemodynamic variables in the normal myocardium. Propofol produced a concentration-dependent decrease in the variables of contractility, LVDP and dP/dftnax, and an increase in coronary flow. However, propofol 1 jug ml" 1 in the ischaemia-reperfusion experiments had no effect on LVDP, dP/d/max or coronary flow. In contrast, Intralipid had no effect on these variables at any concentration.
Results

Effect of propofol and Intralipid on normal myocardium
Ischaemia-reperfusion experiments
A total of 47 hearts were used in the study: 11 did not fulfil the predefined quality criteria (LVDP >95 mm Hg at a coronary flow of 10-16 ml min" 1 and no ventricular fibrillation during the stabilization period). These hearts were excluded. Mean heart wet weight was comparable in all groups (control group 1.16 (0.05) g; Intralipid group 1.07 (0.05) g; propofol group 1.07 (0.07) g).
Haemodynamic function
Under baseline conditions, haemodynamic variables were similar in all groups. Figure 2 shows LVDP and coronary flow during the course of the experiment. In the control, Intralipid and propofol groups, LAD occlusion caused similar decreases in coronary flow to 45 (2)% of baseline (P<0.001). After release of LAD occlusion, coronary flow returned to baseline in all groups (97 (2)% of baseline after 15 min of reperfusion; P=1.0), and then decreased slowly to 66 (2)% of baseline at the end of the reperfusion period. During LAD occlusion, LVDP decreased to 28 (2)% of baseline (P<0.001) with recovery to 78 (3)% of baseline after 15 min of reperfusion. LVDP did not return to baseline values (P<0.001) and was impaired further at the end of the reperfusion period (60 (3)% of baseline). This effect was similar in all groups. Table 1 shows LV d/7dftnax and dP/dtmin. d/Vd/max, a variable of myocardial contractility, was reduced after LAD occlusion to 36 (2)% of baseline (/><0.001), recovered to 78 (3)% of baseline (P<0.001) and remained reduced compared with baseline until the end of the reperfusion period (67 (3)% of baseline; P<0.001).
As a variable of diastolic function, d/Vdmiin changed similarly during occlusion (P<0.00l) and reperfusion (P<0.001). There were no significant differences between the three groups for any haemodynamic variable.
Myocardial oxygen consumption
Under baseline conditions, VQ 2 was similar in all groups (Fig. 3) . LAD occlusion impaired reperfusion period. There were no differences between the three groups during occlusion or reperfusion.
Infarct size
Infarct size (Fig. 4) 
Discussion
We have examined the effects of propofol on myocardial lethal reperfusion injury, defined as myocyte cell death caused by reperfusion itself rather than by the preceding ischaemia. 18 There is a burst of free oxygen radicals within the first few minutes of reperfusion, 3 attacking lipids that constitute the cell membrane and membrane proteins involved in the transport of ions and maintenance of cellular ionic homeostasis. 19 Several studies showed a reduction of lethal reperfusion injury by administration of oxygen radical scavengers. 4 
"
6 The calcium overload phenomenon is another important factor in myocardial reperfusion injury and calcium antagonists are known to reduce myocardial reoxygenation damage. 15 16 Propofol may interfere with both mechanisms, suggesting a cardioprotective effect in myocardial reperfusion.
Plasma concentrations of propofol during clinical use are 0.7-20 |ig ml" 1 . 12 Considering that 97-99% of propofol is protein bound, 20 effective free plasma concentrations are 0. 6 fig ml" 1 or less. 21 Thus our concentration of propofol 1 fig ml~' is comparable with clinically achieved free plasma concentrations. Administration of higher concentrations of propofol would not have allowed conclusions of clinical relevance. In our study, this would have affected myocardial contractility, and the beneficial effect of partial and complete contractile block on lethal reperfusion injury is already known. 22 23 Therefore, administration of propofol at higher concentrations may show an effect on lethal reperfusion injury but it would be difficult to distinguish a specific cardioprotective effect caused by antioxidant and calcium channel blocking effects from a general effect caused by a reduction in preload, afterload and inotropy.
In our study, propofol at a clinically relevant concentration of 1 fig ml" 1 did not cause a reduction in infarct size. There were no differences between groups in LV systolic performance (LVDP, d/Vdftnax), LV diastolic properties (dP/dmiin), coronary flow or myocardial oxygen consumption. This is similar to the findings of other studies which examined non-lethal reperfusion injury (myocardial stunning). These studies failed to show a beneficial effect of propofol on post-ischaemic functional recovery. 24 25 One can speculate why propofol did not provide protection against lethal reperfusion injury in our study. Apart from the fact that propofol may not produce such an effect, a concentration of 1 fig ml" 1 may not have been large enough to exert this effect. Propofol, at this concentration, does not appear to scavenge a sufficient number of free oxygen radicals to reduce myocardial damage significantly. Also, the calcium channel blocking property may not have been powerful enough at a concentration that had no effect on inotropy. Nevertheless, studies have shown a reduction in lethal reperfusion injury by diltiazem in concentrations that had no effect on haemodynamic state, including variables of contractility. 15 16 Absence of reperfusion injury in this study as a possible cause for the lack of protection is unlikely as the isolated rat heart is used commonly to investigate reperfusion injury and several studies showed a reduction in myocardial reperfusion damage using this model. 26 - 28 Ko and colleagues reported a cardioprotective effect of propofol on myocardial ischaemia-reperfusion injury in the isolated rat heart. 29 They used 5-17 times higher concentrations than us and therefore their findings may be explained by the cardiodepressant effect of propofol which caused markedly decreased oxygen demand during occlusion, modulating the severity of ischaemia. The importance of inotropy and heart rate in the extent of ischaemiareperfusion injury is well known and explains the cardioprotective effect of cardiodepressant drugs such as (3 blockers, 30 calcium antagonists 31 and bradycardic agents 32 given before and during ischaemia. However, no conclusion on reperfusion injury can be drawn from their study because propofol was given before global ischaemia and not during reperfusion.
The tendency of a smaller infarct size in the Intralipid group compared with the control group may reflect a small cardioprotective effect of Intralipid. Some interaction between Intralipid and H 2 O 2 has been suggested. 8 Kamikawa and Yamazaki showed that Intralipid and heparin administration decreased free radical formation in mitochondria isolated from normal and ischaemic dog hearts, 33 and mitochondria are an important source of free oxygen radicals in the ischaemic and reperfused myocardium. 19 If Intralipid itself reduced the amount of free oxygen radicals, this could explain the lack of an additional cardioprotective effect of propofol in our study. However, our study was not designed to investigate the influence of Intralipid on the formation of or effects on free oxygen radicals in reperfused myocardium, and does not have the statistical power to prove or disprove such a small protective effect. Our power analysis showed that we would have detected a difference in infarct size of less then 15% of the area at risk. Therefore, it is unlikely that we missed an effect of clinical relevance, particularly as Intralipid did not increase myocardial oxygen consumption or contractile function during reperfusion, which would be expected after a significant reduction in myocardial damage.
In summary, we found that a clinically relevant concentration of propofol, given during early reperfusion, did not reduce cellular damage in the isolated rat heart and did not lead to better functional recovery. Thus propofol seems to have no specific effect on lethal myocardial reperfusion injury. In contrast, some volatile anaesthetics protect the myocardium against reperfusion injury, 34 "
36 and may possibly be beneficial in ischaemia-reperfusion situations compared with total i.v. anaesthesia with propofol.
